Anthony L. Boral - Net Worth and Insider Trading
Anthony L. Boral Net Worth
The estimated net worth of Anthony L. Boral is at least $3 Million dollars as of 2024-09-21. Anthony L. Boral is the Chief Medical Officer of Blueprint Medicines Corp and owns about 28,147 shares of Blueprint Medicines Corp (BPMC) stock worth over $3 Million. Details can be seen in Anthony L. Boral's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Anthony L. Boral has not made any transactions after 2020-12-14 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Anthony L. Boral
Anthony L. Boral Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Anthony L. Boral owns 1 companies in total, including Blueprint Medicines Corp (BPMC) .
Click here to see the complete history of Anthony L. Boral’s form 4 insider trades.
Insider Ownership Summary of Anthony L. Boral
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| BPMC | Blueprint Medicines Corp | 2020-12-14 | Sr. VP & Clinical Development |
Anthony L. Boral Latest Holdings Summary
Anthony L. Boral currently owns a total of 1 stock. Anthony L. Boral owns 28,147 shares of Blueprint Medicines Corp (BPMC) as of December 14, 2020, with a value of $3 Million.
Latest Holdings of Anthony L. Boral
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| BPMC | Blueprint Medicines Corp | 2020-12-14 | 28,147 | 91.72 | 2,581,643 |
Holding Weightings of Anthony L. Boral
Anthony L. Boral Form 4 Trading Tracker
According to the SEC Form 4 filings, Anthony L. Boral has made a total of 5 transactions in Blueprint Medicines Corp (BPMC) over the past 5 years, including 0 buys and 5 sells. The most-recent trade in Blueprint Medicines Corp is the sale of 10,000 shares on December 14, 2020, which brought Anthony L. Boral around $1 Million.
Insider Trading History of Anthony L. Boral
- 1
Anthony L. Boral Trading Performance
Anthony L. Boral Ownership Network
Anthony L. Boral Owned Company Details
What does Blueprint Medicines Corp do?
Who are the key executives at Blueprint Medicines Corp?
Anthony L. Boral is the Sr. VP & Clinical Development of Blueprint Medicines Corp. Other key executives at Blueprint Medicines Corp include director & CEO & President Jeffrey W. Albers , Principal FAO Michael Landsittel , and Chief Commercial Officer Philina Lee .
Blueprint Medicines Corp (BPMC) Insider Trades Summary
Over the past 18 months, Anthony L. Boral made no insider transaction in Blueprint Medicines Corp (BPMC). Other recent insider transactions involving Blueprint Medicines Corp (BPMC) include a net sale of 165,808 shares made by Jeffrey W. Albers , a net sale of 38,146 shares made by Michael Landsittel , and a net sale of 14,415 shares made by Ariel Hurley .
In summary, during the past 3 months, insiders sold 78,691 shares of Blueprint Medicines Corp (BPMC) in total and bought 0 shares, with a net sale of 78,691 shares. During the past 18 months, 461,233 shares of Blueprint Medicines Corp (BPMC) were sold and 0 shares were bought by its insiders, resulting in a net sale of 461,233 shares.
Blueprint Medicines Corp (BPMC)'s detailed insider trading history can be found in Insider Trading Tracker table.
Blueprint Medicines Corp Insider Transactions
Anthony L. Boral Mailing Address
Above is the net worth, insider trading, and ownership report for Anthony L. Boral. You might contact Anthony L. Boral via mailing address: Blueprint Medicines Corp., 215 First Street, Suite 340/350, Cambridge Ma 02142.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
